| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A phase I/II trial of GW572016 (lapatinib) in recurrent glioblastoma multiforme: clinical outcomes, pharmacokinetics and molecular correlation
|
Thiessen, Brian
|
|
2009
|
65 |
2 |
p. 353-361
|
artikel
|
| 2 |
A phase I study of larotaxel (XRP9881) administered in combination with carboplatin in chemotherapy-naïve patients with stage IIIB or stage IV non-small cell lung cancer
|
Robert, Francisco
|
|
2009
|
65 |
2 |
p. 227-234
|
artikel
|
| 3 |
A phase I trial of UCN-01 and prednisone in patients with refractory solid tumors and lymphomas
|
Kummar, Shivaani
|
|
2009
|
65 |
2 |
p. 383-389
|
artikel
|
| 4 |
A randomized comparative study of high-dose and low-dose hepatic arterial infusion chemotherapy for intractable, advanced hepatocellular carcinoma
|
Woo, Hyun Young
|
|
2009
|
65 |
2 |
p. 373-382
|
artikel
|
| 5 |
Association of UGT2B7 and ABCB1 genotypes with morphine-induced adverse drug reactions in Japanese patients with cancer
|
Fujita, Ken-ichi
|
|
2009
|
65 |
2 |
p. 251-258
|
artikel
|
| 6 |
A water soluble prodrug of a novel camptothecin analog is efficacious against breast cancer resistance protein-expressing tumor xenografts
|
Endo, Mika
|
|
2009
|
65 |
2 |
p. 363-371
|
artikel
|
| 7 |
Bevacizumab induced reversible thrombocytopenia in a patient with recurrent high-grade glioma: a case report
|
Leal, Ticiana
|
|
2009
|
65 |
2 |
p. 399-401
|
artikel
|
| 8 |
Bexarotene: a promising anticancer agent
|
Qu, Liyan
|
|
2009
|
65 |
2 |
p. 201-205
|
artikel
|
| 9 |
Capped-dose mitomycin C: a pooled safety analysis from three prospective clinical trials
|
Ntukidem, Nse
|
|
2009
|
65 |
2 |
p. 319-324
|
artikel
|
| 10 |
Celecoxib prevents tumor growth in an animal model by a COX-2 independent mechanism
|
Bastos-Pereira, Amanda Leite
|
|
2009
|
65 |
2 |
p. 267-276
|
artikel
|
| 11 |
Dual targeting of tumour cells and host endothelial cells by novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines
|
Nathwani, Seema-Maria
|
|
2009
|
65 |
2 |
p. 289-300
|
artikel
|
| 12 |
Effect of antisense oligomer in controlling c-raf.1 overexpression during diethylnitrosamine-induced hepatocarcinogenesis in rat
|
Das, Tanushree
|
|
2009
|
65 |
2 |
p. 309-318
|
artikel
|
| 13 |
Mechanism-based receptor-binding model to describe the pharmacokinetic and pharmacodynamic of an anti-α5β1 integrin monoclonal antibody (volociximab) in cancer patients
|
Ng, Chee M.
|
|
2009
|
65 |
2 |
p. 207-217
|
artikel
|
| 14 |
Phase 1 first-in-human clinical study of S-trans, trans-farnesylthiosalicylic acid (salirasib) in patients with solid tumors
|
Tsimberidou, Apostolia Maria
|
|
2009
|
65 |
2 |
p. 235-241
|
artikel
|
| 15 |
Phase I clinical and pharmacokinetic study of the glucose-conjugated cytotoxic agent d-19575 (glufosfamide) in patients with solid tumors
|
Shimizu, Toshio
|
|
2009
|
65 |
2 |
p. 243-250
|
artikel
|
| 16 |
Phase I/II study of the lipiodolization using DDP-H (CDDP powder; IA-call®) in patients with unresectable hepatocellular carcinoma
|
Yamashita, Yo-ichi
|
|
2009
|
65 |
2 |
p. 301-307
|
artikel
|
| 17 |
Phase II study of fixed dose rate gemcitabine as radiosensitizer for newly diagnosed glioblastoma multiforme
|
Metro, Giulio
|
|
2009
|
65 |
2 |
p. 391-397
|
artikel
|
| 18 |
Preclinical rationale for combined use of endocrine therapy and 5-fluorouracil but neither doxorubicin nor paclitaxel in the treatment of endocrine-responsive breast cancer
|
Kurebayashi, Junichi
|
|
2009
|
65 |
2 |
p. 219-225
|
artikel
|
| 19 |
Promising overall survival of patients with recurrent/metastatic squamous cell carcinoma of head and neck receiving gemcitabine plus cisplatin treatment: report of a multi-center phase II study
|
Yang, Muh-Hwa
|
|
2009
|
65 |
2 |
p. 259-265
|
artikel
|
| 20 |
Quantitative structure–property relationships of camptothecins in humans
|
Xu, Chao
|
|
2009
|
65 |
2 |
p. 325-333
|
artikel
|
| 21 |
Quercetin greatly improved therapeutic index of doxorubicin against 4T1 breast cancer by its opposing effects on HIF-1α in tumor and normal cells
|
Du, Gangjun
|
|
2009
|
65 |
2 |
p. 277-287
|
artikel
|
| 22 |
The contribution of deleterious DPYD gene sequence variants to fluoropyrimidine toxicity in British cancer patients
|
Loganayagam, Aathavan
|
|
2009
|
65 |
2 |
p. 403-406
|
artikel
|
| 23 |
The effect of transcatheter arterial chemoembolization on phase II drug metabolism enzymes in patients with hepatocellular carcinoma
|
Zhang, Yan
|
|
2009
|
65 |
2 |
p. 347-352
|
artikel
|
| 24 |
Tyrosine kinase inhibitors and multidrug resistance proteins: interactions and biological consequences
|
Azzariti, Amalia
|
|
2009
|
65 |
2 |
p. 335-346
|
artikel
|
Tijdschrift beschrijving